FDAFDA · Food and drugs·Recall number D-0274-2024
Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by:Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01
Published February 7, 2024 · Recall initiated: January 3, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CEFIXIME
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0368180423089
- Lot
- Lot #: F304833, Exp 06/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.